Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib. Papadimitriou M, Papadimitriou CA. Anticancer Res 2021;41:567-582.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Papadimitriou M, Papadimitriou CA. Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib. Anticancer Res 2021;41:567-582.
PMID: 33517262